Endothelial cells-derived SEMA3G suppresses glioblastoma stem cells by inducing c-Myc degradation.
Saved in:
| Title: | Endothelial cells-derived SEMA3G suppresses glioblastoma stem cells by inducing c-Myc degradation. |
|---|---|
| Authors: | Min PX; Key Laboratory of Modern Toxicology of Ministry of Education; School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.; The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, China., Feng LL; Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Jiangsu Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, School of Pharmacy, Nanjing Medical University, Nanjing, China., Zhang YX; Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Jiangsu Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, School of Pharmacy, Nanjing Medical University, Nanjing, China., Jiang CC; Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Jiangsu Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, School of Pharmacy, Nanjing Medical University, Nanjing, China., Zhang HZ; Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Jiangsu Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, School of Pharmacy, Nanjing Medical University, Nanjing, China., Chen Y; Key Laboratory of Modern Toxicology of Ministry of Education; School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China., Fukunaga K; Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, Miyagi, Japan., Liu F; The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, China., Zhang YJ; Key Laboratory of Modern Toxicology of Ministry of Education; School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China., Sasaki T; Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan., Qian X; Department of Neurosurgery of First Affiliated Hospital of Nanjing Medical University, Department of Nutrition and Food Hygiene of School of Public Health, Nanjing Medical University, Nanjing, China., Horimoto K; SOCIUM Inc. AIST Waterfront Center Annex 5 F, Aomi 2-4-7, Kotoku, Tokyo, Japan.; Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, Japan., Jiang JD; Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Jiangsu Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, School of Pharmacy, Nanjing Medical University, Nanjing, China. jiang.jdong@163.com.; Department of Virology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. jiang.jdong@163.com., Lu YM; Key Laboratory of Modern Toxicology of Ministry of Education; School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China. lufx@njmu.edu.cn.; Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. lufx@njmu.edu.cn., Han F; Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education; International Joint Laboratory for Drug Target of Critical Illnesses; Jiangsu Key Laboratory of Drug Targets and Translational Medicine for Cardio-cerebrovascular Diseases, School of Pharmacy, Nanjing Medical University, Nanjing, China. fenghan169@njmu.edu.cn.; Institute of Brain Science, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China. fenghan169@njmu.edu.cn.; The affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Northern Jiangsu Institute of Clinical Medicine, Huaian, China. fenghan169@njmu.edu.cn. |
| Source: | Cell death and differentiation [Cell Death Differ] 2025 Dec; Vol. 32 (12), pp. 2340-2354. Date of Electronic Publication: 2025 Jun 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5403 (Electronic) Linking ISSN: 13509047 NLM ISO Abbreviation: Cell Death Differ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
